Literature DB >> 1923797

Construction of a novel RNA-transcript-trimming plasmid which can be used both in vitro in place of run-off and (G)-free transcriptions and in vivo as multi-sequences transcription vectors.

K Taira1, K Nakagawa, S Nishikawa, K Furukawa.   

Abstract

We have constructed a new transcription system that allows trimming of both 5' and 3'-termini of any RNA transcripts by means of cis-acting ribozyme activities. The vector consists of a promoter, '5' Processing Ribozyme', any DNA template to be transcribed, and '3' Processing Ribozyme' sequences. When the vector possessing T7 promoter was tested in vitro, the transcription efficiency from the circular template was over ten-fold higher than using linearized template (run-off transcription). Further, since uniform RNAs with defined 5'- and 3'-ends can be produced, this strategy complements the conventional run-off transcription. Also the 5'-/3'-trimmed uniform RNA can function as a reporter in elucidating transcription factors and promoter regions in vitro, this strategy can replace the widely used (G)-free transcription (Sawadogo and Roeder (1985) Proc. Natl. Acad. Sci. USA 82, 4394-4398). With this strategy, in addition to the advantage that the template DNA need not be linearized prior to transcription, a cytidine-minus sequence is no longer necessary for quantitative analysis of transcription factors. Since any sequences including those of RNA virus can be inserted between the '5' Processing Ribozyme' and the '3' Processing Ribozyme' sequences, and the entire unit can be inserted into any genes under active transcription, this construct is useful like that of Dzianott and Bujarski ((1989) Proc. Natl. Acad. Sci. USA 86, 4823-4827) for RNA virologists because these strategies provide RNA transcripts without heterologous sequences which may greatly diminish infectivity. Moreover, since the construct can also be used in vivo, multi-transcripts such as trans-acting ribozymes targeted to various sites would be produced by concatenating the entire units in tandem.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1923797      PMCID: PMC328865          DOI: 10.1093/nar/19.19.5125

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  17 in total

1.  In vivo RNA transcript-releasing plasmid possessing a universal pseudo-terminator by means of artificial ribozymes.

Authors:  M Ohme-Takagi; H Shinshi; M Oda; T Uchimaru; S Nishikawa; K Taira
Journal:  Nucleic Acids Symp Ser       Date:  1990

2.  Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites.

Authors:  A C Forster; R H Symons
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

3.  Simple RNA enzymes with new and highly specific endoribonuclease activities.

Authors:  J Haseloff; W L Gerlach
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

Review 4.  Ribonuclease P: an enzyme with a catalytic RNA subunit.

Authors:  S Altman
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1989

5.  RNA evolution and the origins of life.

Authors:  G F Joyce
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

6.  A small catalytic oligoribonucleotide.

Authors:  O C Uhlenbeck
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

7.  Construction of a series of several self-cleaving RNA duplexes using synthetic 21-mers.

Authors:  M Koizumi; S Iwai; E Ohtsuka
Journal:  FEBS Lett       Date:  1988-02-15       Impact factor: 4.124

8.  Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay.

Authors:  M Sawadogo; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Derivation of an infectious viral RNA by autolytic cleavage of in vitro transcribed viral cDNAs.

Authors:  A M Dzianott; J J Bujarski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Ribozyme mediated destruction of RNA in vivo.

Authors:  M Cotten; M L Birnstiel
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  11 in total

1.  RNA aptamers as effective protein antagonists in a multicellular organism.

Authors:  H Shi; B E Hoffman; J T Lis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  RNA double cleavage by a hairpin-derived twin ribozyme.

Authors:  C Schmidt; R Welz; S Müller
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

3.  Can hammerhead ribozymes be efficient tools to inactivate gene function?

Authors:  E Bertrand; R Pictet; T Grange
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

4.  Generation of circular RNAs and trans-cleaving catalytic RNAs by rolling transcription of circular DNA oligonucleotides encoding hairpin ribozymes.

Authors:  A M Diegelman; E T Kool
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

5.  Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.

Authors:  S Koseki; T Tanabe; K Tani; S Asano; T Shioda; Y Nagai; T Shimada; J Ohkawa; K Taira
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Characterization of several kinds of dimer minizyme: simultaneous cleavage at two sites in HIV-1 tat mRNA by dimer minizymes.

Authors:  T Kuwabara; S V Amontov; M Warashina; J Ohkawa; K Taira
Journal:  Nucleic Acids Res       Date:  1996-06-15       Impact factor: 16.971

7.  Importance of independence in ribozyme reactions: kinetic behavior of trimmed and of simply connected multiple ribozymes with potential activity against human immunodeficiency virus.

Authors:  J Ohkawa; N Yuyama; Y Takebe; S Nishikawa; K Taira
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

8.  A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.

Authors:  N Yuyama; J Ohkawa; T Koguma; M Shirai; K Taira
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

9.  RNase H cleavage for processing of in vitro transcribed RNA for NMR studies and RNA ligation.

Authors:  J Lapham; D M Crothers
Journal:  RNA       Date:  1996-03       Impact factor: 4.942

10.  Affinity purification of T7 RNA transcripts with homogeneous ends using ARiBo and CRISPR tags.

Authors:  Alix Salvail-Lacoste; Geneviève Di Tomasso; Benjamin L Piette; Pascale Legault
Journal:  RNA       Date:  2013-05-08       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.